(vi) Remdesivir
Remdesivir is a broad-spectrum antiviral drug used to treat many
viruses. It has effective inhibitory effects against many zoonotic
pathogens and human coronaviruses such as Severe Acute Respiratory
Syndrome (SARS). It can limit onset of symptoms from 15 days to 11 in
clinical trials around the world (Bandi, 2020).
“It’s a very safe and effective drug,” said Eric Topol, founder and
director of the Scripps Research Translational Institute. “We now have
a definite first efficacious drug for Covid-19, which is a major step
forward and will be built upon with other drug combinations (Herper,
2020).”
The Gilead and five generic companies of Pakistan and India have signed
agreement so they can help 127 countries for making Remdesivir medicine
to fight against Covid-19 (Bandi, 2020).
A brief review about the available treatments for COVID-19 being
practiced yet is described following in table 5: